Article
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Feb 2014
Shi Yuankai, Au Joseph Siu-Kie, Thongprasert Sumitra, Srinivasan Sankar, Tsai Chun-Ming, Khoa Mai Trong, Heeroma Karin, Itoh Yohji, Cornelio Gerardo, Yang Pan-Chyr
Abstract excerpt
INTRODUCTION: PIONEER (NCT01185314) was a prospective, multinational, epidemiological study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly diagnosed advanced lung adenocarcinoma. METHODS: Eligible patients (aged ≥20 years) had untreated stage IIIB/IV adenocarcinoma. The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor samples (biopsy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
